Axon Enterprise, Inc. Treasury Stock increased by 14.6% to $180.16M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.5%, from $155.95M to $180.16M. Over 5 years (FY 2020 to FY 2025), Treasury Stock shows relatively stable performance with a 0.2% CAGR.
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
treasury_stock| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $155.95M | $157.24M | $180.16M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.8% | +14.6% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.8% | +15.5% |